alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
{"version":"1.0","provider_name":"Federal Maritime Commission","provider_url":"https:\/\/www.fmc.gov","author_name":"Catie-Megan Moran","author_url":"https:\/\/www.fmc.gov\/author\/cmoranfmc-gov\/","title":"Comments of Federal Maritime Commissioner Rebecca F. Dye at the Western Cargo Conference (WESCCON)","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"rM1z86r35G\"><a href=\"\/comments-of-federal-maritime-commissioner-rebecca-f-dye-at-the-western-cargo-conference-wesccon\/\">Comments of Federal Maritime Commissioner Rebecca F. Dye at the Western Cargo Conference (WESCCON)<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"\/comments-of-federal-maritime-commissioner-rebecca-f-dye-at-the-western-cargo-conference-wesccon\/embed\/#?secret=rM1z86r35G\" width=\"600\" height=\"338\" title=\"“Comments of Federal Maritime Commissioner Rebecca F. Dye at the Western Cargo Conference (WESCCON)” — Federal Maritime Commission\" data-secret=\"rM1z86r35G\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/*! This file is auto-generated *\/\n!function(c,l){\"use strict\";var e=!1,o=!1;if(l.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(\/[^a-zA-Z0-9]\/.test(t.secret));else{for(var r,s,a,i=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),n=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),o=0;o<n.length;o++)n[o].style.display=\"none\";for(o=0;o<i.length;o++)if(r=i[o],e.source!==r.contentWindow);else{if(r.removeAttribute(\"style\"),\"height\"===t.message){if(1e3<(s=parseInt(t.value,10)))s=1e3;else if(~~s<200)s=200;r.height=s}if(\"link\"===t.message)if(s=l.createElement(\"a\"),a=l.createElement(\"a\"),s.href=r.getAttribute(\"src\"),a.href=t.value,a.host===s.host)if(l.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener(\"message\",c.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",t,!1),c.addEventListener(\"load\",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf(\"MSIE 10\"),a=!!navigator.userAgent.match(\/Trident.*rv:11\\.\/),i=l.querySelectorAll(\"iframe.wp-embedded-content\"),n=0;n<i.length;n++){if(!(r=(t=i[n]).getAttribute(\"data-secret\")))r=Math.random().toString(36).substr(2,10),t.src+=\"#?secret=\"+r,t.setAttribute(\"data-secret\",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute(\"security\"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:\"ready\",secret:r},\"*\")}}}}(window,document);\n<\/script>\n"}
Exhibit
23.1




CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM




The Board
of Directors


ENSURAPET,
INC.




We hereby
consent to the use in this Annual Report of ENSURAPETE, INC. of our report dated
April 24, 2008, for the consolidated balance sheets of ENSURAPET, INC. as
of the period ended December 31, 2007, and the related consolidated
statements of operations, changes in shareholders’ equity, and cash flows for
the for the period s since July 20, 2005 (inception),
December 31, 2006, and through December 31, 2007.




/s/
      Lawrence Scharfman, CPALawrence
      Scharfman, CPABoynton
      Beach, FloridaApril 24,
      2008
**EXHIBIT 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation byreference in Registration Statement (No. 333-134152) on Form S-8, Registration Statement (No. 333-145587) on Form S-3, and Registration Statement (No. 333-148138) on Form S-3 of Basin Water Inc. of our reports dated March 31, 2009 relatingto our audits of the consolidated financial statements, and the financial statement schedule and internal control over financial reporting, which appear in this Annual Report on Form 10-K of Basin Water, Inc. for the year endedDecember 31, 2008. Our report dated March 31, 2009, relating to the consolidated financial statements includes an emphasis paragraph relating to an uncertainty as to the Company’s ability to continue as a going concern. 

Our report dated March 31, 2009, on the effectiveness of internal control over financial reporting as of December 31, 2008, expressed anopinion that Basin Water, Inc. had not maintained effective internal control over financial reporting as of December 31, 2008, based on criteria established in Internal Control—Integrated Framework issued by the Committee of SponsoringOrganizations of the Treadway Commission (COSO). 

/s/  SINGERLEWAK LLP 

Irvine, California 

March 31, 2009
Exhibit 4.1



 


THE BANK OF NEW YORK MELLON


NEW YORK’S FIRST BANK-FOUNDED 1784 BY ALEXANDER HAMILTON


 


 


240 Greenwich
Street, 22W Floor, New York, NY 10286


 


 


 


April 26, 2022


 


Hennion & Walsh, Inc.


2001 Route 46, Waterview Plaza


Parsippany, New Jersey 07054


 


SmartTrust 563 (the “Fund”)


 


Dear Sirs:


The Bank of New York Mellon
is acting as trustee for the Fund, consisting of the unit investment trusts (the “Trusts”) included in the Registration
Statement relating to the Fund. We enclosed a list of the securities to be deposited in the Trusts on the date hereof. The prices indicated
therein reflect our evaluation of such securities as of close of business on April 25, 2022, in accordance with the valuation method set
forth in the applicable Standard Terms and Conditions of Trust and Trust Agreements. We consent to the reference to The Bank of New York
Mellon as the party performing the evaluations of the Trust securities in the Registration Statement (No. 333-262211) filed with the Securities
and Exchange Commission with respect to the registration of the sale of the Units of the Trusts and to the filing of this consent as an
exhibit thereto.


 


Very truly yours,


 


/s/  Margarita
Kalantarova


Margarita Kalantarova


Vice President
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in Local Rule 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

__________________ No. 96-40854 Summary Calendar

__________________ UNITED STATES OF AMERICA, Plaintiff-Appellee,
versus NELSON GLEN BRISCOE; ANTHONY QUINN BLAIR, Defendants-Appellants

- - - - - - - - - - Appeal from the United States District Court for the Eastern District of Texas USDC No. 4:96-CR-10-01
- - - - - - - - - - May 30, 1997 Before JONES, DeMOSS and PARKER, Circuit Judges. PER CURIAM: * Anthony Quinn Blair and Nelson Glen Briscoe argue that the district court abused its discretion by admitting the testimony of Government witnesses discovered after the jury was selected but before the jury was sworn. Briscoe also argues that there was insufficient evidence to support his convictions of being an armed career criminal in possession of a firearm and sellingNo. 96-40854 -2- stolen firearms because witness testimony was not credible. We have reviewed the record and the Appellants' contentions and we find no reversible error. See United States v. Brock , 833 F.2d 519, 522 (5th Cir. 1987); United States v. Casteneda , 951 F.2d 44, 48 (5th Cir. 1992). AFFIRMED.
COMPROMISE AGREEMENT
FMC File No. 17261

This Compromise Agreement is entered into between:

(1) the Federal Maritime Commission (Commission); and

(2) Bayani Commercial, Inc. (Respondent).

WHEREAS, the Commission is considering the initiation of an assessment proceeding
against Respondent for the recovery of civil penalties for alleged violation of 46 C.F.R. §515.20(c).

WHEREAS, such proceeding would be based on the Commission’s allegation that
Respondent engaged in certain practices, to wit:

Respondent operated without a Qualifying Individual as required under
46 C.F.R. Part 515 for a period in excess of one year.

WHEREAS, the Commission is authorized under section 13(c) of the Shipping Act, 46
U.S.C. § 41109(c), and Subpart W of the Commission’s Rules of Practice and Procedure, 46 C.F.R.
§ 502.601 — 502.605, to compromise and collect civil penalties for the alleged violation set forth
and described above; and,

WHEREAS, Respondent terminated the practice that was the basis of the alleged violation
set forth herein, and has committed to maintain measures designed to eliminate such practice in
the future; and,

WHEREAS, Respondent has cooperated and disclosed to the Commission information,
facts, and documents relevant to its transportation activities and practices; and,

NOW THEREFORE, in consideration of the premises herein, and in compromise of all
civil penalties arising from the alleged violation set forth above and described herein, Respondent

and the Commission hereby agree upon the following terms of settlement:


. Respondent shall make payment to the Commission by cashier’s or certified check or
by wire transfer in the amount of $25,000.00.

. This Compromise Agreement shall forever bar the commencement or institution of any
assessment proceeding or other claim of recovery of civil penalties from Respondent,
its officers, directors, or employees arising from the alleged violation set forth above
that occurred for a period in excess of one year prior to January 16, 2018.

. It is expressly understood that this Compromise Agreement is not, and is not to be
construed as, an admission by Respondent to the alleged violation set forth above.

. This agreement is subject to approval by the Commission’s Managing Director in

accordance with 46 C.F.R. § 502.604.

Signature:

Printed Name: Daud 0. wtansi |
title: Pusidley-+
Date: Avyyot 2), 101%



APPROVAL AND ACCEPTANCE OF COMPROMISE AGREEMENT

FMC File No.17261

The above Terms and Conditions and Amount of Consideration are hereby approved and

accepted:

By the Federal Maritime Commission:

Ks) — Fa /F

Director (Date)
Bureau of Enforcement

Karo Kreme ${22/2a1y

Karen V. Gregory iG = (Date)
Managing Director
**Exhibit 31.1**
 **CERTIFICATIONS**
 
  **Certification Pursuant to Rule 13a-14(a) of the Exchange Act**
   I, Eran Broshy, Chief Executive Officer of Ventiv Health, Inc., certify that:
  1.  I have reviewed this quarterly report on Form 10-Q of Ventiv Health, Inc.;
 
 2.  Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
 
 3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
 
 4.  The registrants other certifying officer and I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:
 
 a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; 
 b)
evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 
 c)
disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect the registrants internal control over financial reporting; and 
 5.  The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors:
 
 a)
all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and 
 b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. 
 
 
 DATE: November 9, 2004

By:

/S/    ERANBROSHY**Eran Broshy**
**Chief Executive Officer** 
  24
{"version":"1.0","provider_name":"Federal Maritime Commission","provider_url":"https:\/\/www.fmc.gov","author_name":"Catie-Megan Moran","author_url":"https:\/\/www.fmc.gov\/author\/cmoranfmc-gov\/","title":"Chairman Cordero Testifies to Congress Regarding FY 2014 FMC Budget","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"LXb0MvLc1p\"><a href=\"\/chairman-cordero-testifies-to-congress-regarding-fy-2014-fmc-budget\/\">Chairman Cordero Testifies to Congress Regarding FY 2014 FMC Budget<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"\/chairman-cordero-testifies-to-congress-regarding-fy-2014-fmc-budget\/embed\/#?secret=LXb0MvLc1p\" width=\"600\" height=\"338\" title=\"“Chairman Cordero Testifies to Congress Regarding FY 2014 FMC Budget” — Federal Maritime Commission\" data-secret=\"LXb0MvLc1p\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/*! This file is auto-generated *\/\n!function(c,l){\"use strict\";var e=!1,o=!1;if(l.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(\/[^a-zA-Z0-9]\/.test(t.secret));else{for(var r,s,a,i=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),n=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),o=0;o<n.length;o++)n[o].style.display=\"none\";for(o=0;o<i.length;o++)if(r=i[o],e.source!==r.contentWindow);else{if(r.removeAttribute(\"style\"),\"height\"===t.message){if(1e3<(s=parseInt(t.value,10)))s=1e3;else if(~~s<200)s=200;r.height=s}if(\"link\"===t.message)if(s=l.createElement(\"a\"),a=l.createElement(\"a\"),s.href=r.getAttribute(\"src\"),a.href=t.value,a.host===s.host)if(l.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener(\"message\",c.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",t,!1),c.addEventListener(\"load\",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf(\"MSIE 10\"),a=!!navigator.userAgent.match(\/Trident.*rv:11\\.\/),i=l.querySelectorAll(\"iframe.wp-embedded-content\"),n=0;n<i.length;n++){if(!(r=(t=i[n]).getAttribute(\"data-secret\")))r=Math.random().toString(36).substr(2,10),t.src+=\"#?secret=\"+r,t.setAttribute(\"data-secret\",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute(\"security\"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:\"ready\",secret:r},\"*\")}}}}(window,document);\n<\/script>\n"}
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3475 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 3475

 To amend the Public Health Service Act to double the amount of funds 
authorized to be appropriated to the National Institutes of Health for 
  medical research with the greatest potential for near-term clinical 
                                benefit.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 31, 2009

  Mr. Forbes introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
 To amend the Public Health Service Act to double the amount of funds 
authorized to be appropriated to the National Institutes of Health for 
  medical research with the greatest potential for near-term clinical 
                                benefit.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Accelerate Cures for Patients Act of 
2009''.

SEC. 2. ADDITIONAL NIH FUNDING FOR RESEARCH WITH GREATEST POTENTIAL FOR 
              NEAR-TERM CLINICAL BENEFIT.

    Title IV of the Public Health Service Act (42 U.S.C. 281 et seq.) 
is amended by inserting after section 402A the following:

``SEC. 402A-1. ADDITIONAL FUNDING FOR RESEARCH WITH GREATEST POTENTIAL 
              FOR NEAR-TERM CLINICAL BENEFIT.

    ``In addition to the amount authorized to be appropriated each 
fiscal year pursuant to section 402A to conduct or support medical 
research under this title, there is authorized to be appropriated an 
equal amount for medical research (relating to cancer, cardiovascular 
disease, diabetes, Alzheimer's disease, Parkinson's disease, or other 
diseases or conditions) that (as determined by the Secretary) has the 
greatest potential for near-term clinical benefit in human patients, as 
indicated by substantial evidence from basic research or by substantial 
clinical evidence. Such evidence may include but is not limited to--
            ``(1) evidence of improvement in one or more human patients 
        suffering from illness or injury, as documented in reports by 
        professional medical or scientific associations or in peer-
        reviewed medical or scientific literature; or
            ``(2) approval for use in human trials by the Food and Drug 
        Administration.''.
                                 <all>
```
EXHIBIT 32



CERTICATION PURSUANT TO

18 U.S.C. SECTION
1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Each of the undersigned
hereby certifies, pursuant to 18 U.S.C. Section 1350, in his capacity as an officer of Community Bancorp Inc. (the Company) that, to his knowledge, the Quarterly Report of the Company on Form 10-Q for the period ended March 31, 2005
fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition of the Company at the end of such
period and the results of operations of the Company for such period.



|                  |  |  |  |                                      
|----------------- |  |  |  | -------------------------------------
|                  |  | 
|Date: May 5, 2005 |  |  |  | /s/ Michael J. Perdue                
|                  |  |  |  | Michael J. Perdue                    
|                  |  |  |  | President and Chief Executive Officer



|                  |  |  |  |                                            
|----------------- |  |  |  | -------------------------------------------
|                  |  | 
|Date: May 5, 2005 |  |  |  | /s/ L. Bruce Mills, Jr.                    
|                  |  |  |  | L. Bruce Mills, Jr.                        
|                  |  |  |  | Sr. Vice President, Chief Financial Officer



A signed original of this written
statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to
Community Bancorp Inc. and will be retained by Community Bancorp Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 82, Number 208 (Monday, October 30, 2017)]
[Notices]
[Page 50151]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23459]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Integrative Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the ZAT1 VS (07).
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Integrative Health Special Emphasis Panel; Research Resource for 
Systematic Reviews of Complementary and Integrative Health (R24).
    Date: December 5, 2017.
    Time: 1:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Viatcheslav A. Soldatenkov, MD, Ph.D., 
Scientific Review Officer Office of Scientific Review, Division of 
Extramural Activities NCCIH/NIH, 6707 Democracy Boulevard, Suite 
401, Bethesda, MD 20892, <a href="/cdn-cgi/l/email-protection#bccfd3d0d8ddc8d9d2d7d3cacafcd1ddd5d092d2d5d492dbd3ca"><span class="__cf_email__" data-cfemail="23504c4f474257464d484c5555634e424a4f0d4d4a4b0d444c55">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.213, 
Research and Training in Complementary and Alternative Medicine, 
National Institutes of Health, HHS)

    Dated: October 24, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-23459 Filed 10-27-17; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>